YS Biopharma (YS) Short Interest Ratio & Short Volume → Fidelity, Bezos, Goldman Bet Big on Tiny Biotech (From Behind the Markets) (Ad) Free YS Stock Alerts $0.92 +0.12 (+14.38%) (As of 01:40 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media YS Biopharma Short Interest DataCurrent Short Volume95,900 sharesPrevious Short Volume96,900 sharesChange Vs. Previous Month-1.03%Dollar Volume Sold Short$85,351.00Short Interest Ratio / Days to Cover0.4Last Record DateApril 15, 2024Outstanding Shares93,060,000 sharesFloat Size17,940,000 sharesShort Percent of Float0.53%Today's Trading Volume177,950 sharesAverage Trading Volume182,455 sharesToday's Volume Vs. Average98% Short Selling YS Biopharma ? Sign up to receive the latest short interest report for YS Biopharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatYS Short Interest Over TimeYS Days to Cover Over TimeYS Percentage of Float Shorted Over Time Ad Behind the MarketsThe Weight Loss Pill That Could Disrupt a $32 Billion IndustryA revolutionary new weight loss pill is about to send shockwaves through the plus-size clothing market. Analysts are calling it the "King Kong" of diet drugs after amazing clinical trial results.Don't miss out on the "next Ozempic" >>> YS Biopharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/202495,900 shares $85,351.00 -1.0%0.5%0.4 $0.89 3/31/202496,900 shares $69,758.21 -17.0%0.5%0.5 $0.72 3/15/2024116,800 shares $84,446.40 -51.6%0.7%0.6 $0.72 2/29/2024241,400 shares $91,732.00 +25.5%1.4%1.3 $0.38 2/15/2024192,300 shares $80,439.09 +124.7%1.1%1.3 $0.42 1/31/202485,600 shares $36,294.40 +1.7%0.4%0.6 $0.42 Get the Latest News and Ratings for YS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for YS Biopharma and its competitors with MarketBeat's FREE daily newsletter. 1/15/202484,200 shares $44,617.58 -28.5%0.4%0.8 $0.53 12/31/2023117,800 shares $60,195.80 -33.1%0.6%1.3 $0.51 12/15/2023176,200 shares $85,738.92 +7.8%0.9%1.9 $0.49 11/30/2023163,500 shares $91,560.00 -18.2%0.8%1.4 $0.56 11/15/2023199,900 shares $131,734.10 +52.0%1.0%0.2 $0.66 10/31/2023131,500 shares $57,860.00 -12.0%0.7%0.1 $0.44 10/15/2023149,400 shares $103,833.00 +124.7%0.8%0.2 $0.70 9/30/202366,500 shares $53,200.00 -32.4%0.3%0.1 $0.80 9/15/202398,300 shares $88,470.00 -86.1%0.5%0.1 $0.90 8/31/2023706,300 shares $840,497.00 +198.5%3.5%0.5 $1.19 8/15/2023236,600 shares $286,286.00 -23.7%1.2%0.4 $1.21 7/31/2023309,900 shares $440,058.00 +36.2%1.6%0.5 $1.42 7/15/2023227,600 shares $316,364.00 -18.1%1.1%0.3 $1.39 6/30/2023277,800 shares $383,364.00 -83.1%1.4%0.3 $1.38 6/15/20231,640,000 shares $2.26 million +86.1%8.3%1.3 $1.38 5/31/2023881,100 shares $1.33 million -3.3%4.4%1.1 $1.51 5/15/2023911,100 shares $1.13 million No Change4.6%1.2 $1.24 YS Short Interest - Frequently Asked Questions What is YS Biopharma's current short interest? Short interest is the volume of YS Biopharma shares that have been sold short but have not yet been covered or closed out. As of April 15th, traders have sold 95,900 shares of YS short. 0.53% of YS Biopharma's shares are currently sold short. Learn More on YS Biopharma's current short interest. What is a good short interest percentage for YS Biopharma? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.53% of YS Biopharma's floating shares are currently sold short. Is YS Biopharma's short interest increasing or decreasing? YS Biopharma saw a decline in short interest during the month of April. As of April 15th, there was short interest totaling 95,900 shares, a decline of 1.0% from the previous total of 96,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is YS Biopharma's float size? YS Biopharma currently has issued a total of 93,060,000 shares. Some of YS Biopharma's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. YS Biopharma currently has a public float of 17,940,000 shares. How does YS Biopharma's short interest compare to its competitors? 0.53% of YS Biopharma's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to YS Biopharma: Affimed (1.66%), Connect Biopharma Holdings Limited (0.16%), Assertio Holdings, Inc. (11.31%), Assembly Biosciences, Inc. (0.84%), Corvus Pharmaceuticals, Inc. (3.71%), Anebulo Pharmaceuticals, Inc. (0.22%), Spero Therapeutics, Inc. (0.95%), Tempest Therapeutics, Inc. (6.74%), Marinus Pharmaceuticals, Inc. (8.23%), Journey Medical Co. (3.54%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short YS Biopharma stock? Short selling YS is an investing strategy that aims to generate trading profit from YS Biopharma as its price is falling. YS shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against YS Biopharma? A short squeeze for YS Biopharma occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of YS, which in turn drives the price of the stock up even further. How often is YS Biopharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including YS, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Affimed Short Squeeze Connect Biopharma Short Squeeze Assertio Short Squeeze Assembly Biosciences Short Squeeze Corvus Pharmaceuticals Short Squeeze Anebulo Pharmaceuticals Short Squeeze Spero Therapeutics Short Squeeze Tempest Therapeutics Short Squeeze Marinus Pharmaceuticals Short Squeeze Journey Medical Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:YS) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorElon Musk Secret Crypto Plot ExposedCrypto 101 MediaAI “wealth window” is closing June 25thParadigm PressCharles Payne Demystifies OptionsUnstoppable ProsperityShocking: One AI startup's revenue could surge 4,735%Manward PressThe #1 lithium battery stock to have on your radar in 2024!Smallcaps Daily[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsThe AI Stock that’s Disrupting Every IndustryStockEarnings